Products and services

Products and services

Ropinirole Hydrochloride Tablets

Indication: This product is suitable to treat the symptoms and signs of Primary Parkinson’s disease in combination with levodopa.

Strength:0.5mg, 3mg (by ropinirole)

Package: Laminated film package, 30 tablets/carton

Validity:24 months

Approval number:0.5mg: National Medicine Standard H20130044
                  3mg: National Medicine Standard H20130045

- A new generation of selective ergot dopamine receptor agonists;

- It is recommended as first-line medication for early Parkinson’s treatment by the United States, European and Chinese Parkinson's guidelines.

- Its efficacy and safety are demonstrated by over-20-year clinical medication experience abroad.

- The incidence of dyskinesia in early Parkinson's patients is very low, and it can significantly delay the onset of dyskinesia.

-It assists L-dopa in the treatment of patients with advanced Parkinson’s disease. It can effectively shorten the “day off phenomenon” and reduce 20% of the usage amount of L-dopa.